Clinical Trial Update: Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether bupropion can reduce cancer-related fatigue in cancer survivors. The study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Malignant Neoplasm

Drugs mentioned

• Bupropion (Wellbutrin) (bupropion)

Snippet

Sponsor: University of Rochester NCORP Research Base | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING